HomeOGN • NYSE
add
Organon & Co
$9.56
Makalipas ang Oras ng Trabaho:(1.14%)-0.11
$9.45
Sarado: Hun 6, 7:30:14 PM GMT-4 · USD · NYSE · Disclaimer
Nakaraang pagsara
$9.19
Sakop ng araw
$9.28 - $9.64
Sakop ng taon
$8.01 - $23.10
Market cap
2.49B USD
Average na Volume
7.48M
P/E ratio
3.31
Dividend yield
0.84%
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.51B | -6.72% |
Gastos sa pagpapatakbo | 516.00M | -4.97% |
Net na kita | 87.00M | -56.72% |
Net profit margin | 5.75 | -53.59% |
Kita sa bawat share | 1.02 | -16.39% |
EBITDA | 409.00M | -14.61% |
Aktuwal na % ng binabayarang buwis | 13.86% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 547.00M | -4.87% |
Kabuuang asset | 13.16B | 10.64% |
Kabuuang sagutin | 12.61B | 6.51% |
Kabuuang equity | 542.00M | — |
Natitirang share | 259.96M | — |
Presyo para makapag-book | 4.38 | — |
Return on assets | 6.19% | — |
Return on capital | 8.55% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 87.00M | -56.72% |
Cash mula sa mga operasyon | 75.00M | -1.32% |
Cash mula sa pag-invest | -172.00M | -79.17% |
Cash mula sa financing | -75.00M | -1.35% |
Net change in cash | -128.00M | -8.47% |
Malayang cash flow | -73.38M | -288.75% |
Tungkol
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Itinatag
1923
Headquarters
Website
Mga Empleyado
10,000
